EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early start of hemoadsorption is associated with improved kidney recovery in ICU patients with ischemic/reperfusion cause of rhabdomyolysis

Vedran Premuzic iD, Alan Horvat, Mate Mogus, Ivona Vucic iD, Ivan Situm, Tina Tomic-Mahecic iD, Zeljko Colak, Mirabel Mazar, Robert Baronica, Slobodan Mihaljevic

PLOS One · 30.06.2026 · 21 (6) · e0352417

DOI: 10.1371/journal.pone.0352417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.06.2026. Verfasst von Vedran Premuzic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: Rhabdomyolysis, Acute Kidney Injury, Reperfusion Injury, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemoadsorption is considered currently as an adjunct therapy for the treatment of rhabdomyolysis and acute kidney injury (AKI) although the exact timing is not yet determined. We hypothesised that earlier start of hemoadsorption in patients with ischemia/reperfusion caused rhabdomyolysis and AKI leads to a better clinical improvement and recovery of kidney function. Materials and methods We conducted a single-center, retrospective cohort study. Treatment was defined as the use of hemoadsorption with CytoSorb® in combination with continuous renal replacement therapy (CRRT) compared to patients who were treated only with CRRT. Patients were divided in early and late initiation of hemoadsorption subgroups by less or more than 12 hours after developing acute kidney injury. Myoglobin and creatine kinase plasma levels were measured shortly before, 12 hours after the start of treatment, and 24, 48, and 72 hours after initiation. The follow-up lasted until the last enrolled patient reached 60 days after first hemoadsorption procedure.

Results

Overall, 30 patients were included in the treatment arm and 25 patients in the control group. Significant decrease of myoglobin levels was observed in the hemoadsorption treated group in all time points when compared with the control group. Logistical regression analysis found the association of hemoadsorption use and shorter duration of AKI (OR 3.46) and less acute kidney disease (AKD) (OR 2.85). Earlier start of hemoadsorption was associated with a statistically significant shorter duration of AKI (OR 3.22) and less AKD (OR 3.10). Patients treated early with hemoadsorption survived significantly longer than patients treated late (49.2 vs 15.3 days; p < 0.001).

Conclusions

Early start of combined CRRT and hemoadsorption therapy with CytoSorb was safe and associated with improved kidney recovery and survival in patients with ischemic/reperfusion rhabdomyolysis and AKI. Early start of hemoadsorption might prevent renal failure and acute kidney disease and shorten the CRRT dependency in patients who develop AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyolysisAcute Kidney InjuryReperfusion InjuryContinuous Renal Replacement TherapyHumansMaleFemaleRetrospective StudiesMyoglobinMiddle AgedIntensive Care UnitsAgedRecovery of FunctionCreatine KinaseRenal Replacement Therapy

Substanzen

MyoglobinCreatine Kinase

Autor:innen und Institutionen

  • Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, Zagreb, Croatia.
  • School of Medicine, Catholic University of Zagreb, Croatia.
  • Clinic of Anesthesiology, Resuscitation and Intensive Care, University Hospital Center Zagreb, Zagreb, Croatia.
  • School of Medicine, University of Zagreb, Croatia.

ORCID-Profile: Vedran Premuzic, Ivona Vucic, Tina Tomic-Mahecic

Zitieren

APA

Premuzic, V., Horvat, A., Mogus, M., Vucic, I., Situm, I., Tomic-Mahecic, T., Colak, Z., Mazar, M., Baronica, R., & Mihaljevic, S. (2026). Early start of hemoadsorption is associated with improved kidney recovery in ICU patients with ischemic/reperfusion cause of rhabdomyolysis. PLOS One, 21(6), e0352417. https://doi.org/10.1371/journal.pone.0352417

Vancouver

Premuzic V, Horvat A, Mogus M, Vucic I, Situm I, Tomic-Mahecic T, et al. Early start of hemoadsorption is associated with improved kidney recovery in ICU patients with ischemic/reperfusion cause of rhabdomyolysis. PLOS One. 2026;21(6):e0352417. doi:10.1371/journal.pone.0352417

BibTeX
@article{Premuzic2026,
  author = {Premuzic, Vedran and Horvat, Alan and Mogus, Mate and Vucic, Ivona and Situm, Ivan and Tomic-Mahecic, Tina and Colak, Zeljko and Mazar, Mirabel and Baronica, Robert and Mihaljevic, Slobodan},
  title = {Early start of hemoadsorption is associated with improved kidney recovery in ICU patients with ischemic/reperfusion cause of rhabdomyolysis},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0352417},
  doi = {10.1371/journal.pone.0352417}
}
Kostenlos starten →